Keratitis – pipeline review, h1 2012


Published on || Keratitis – Pipeline Review, H1 2012 || Market Research latest report

Published in: Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Keratitis – pipeline review, h1 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Keratitis – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Keratitis - Pipeline Review, H1 2012, provides an overviewof the Keratitis therapeutic pipeline. This report provides information on thetherapeutic development for Keratitis, complete with latest updates, and specialfeatures on late-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Keratitis. Keratitis - Pipeline Review,H1 2012 is built using data and information sourced from Global Markets Direct’sproprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Keratitis.- A review of the Keratitis products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined
  2. 2. therapeutics.Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Keratitis Overview 6Therapeutics Development 7An Overview of Pipeline Products for Keratitis 7Keratitis Therapeutics under Development by Companies 9Keratitis Therapeutics under Investigation by Universities/Institutes 10Mid Clinical Stage Products 11Comparative Analysis 11Early Clinical Stage Products 12Comparative Analysis 12Pre-Clinical Stage Products 13Comparative Analysis 13Keratitis Therapeutics – Products under Development by Companies 14Keratitis Therapeutics – Products under Investigation by Universities/Institutes 15Companies Involved in Keratitis Therapeutics Development 16Menarini Group 16OPKO Health, Inc. 17RegeneRx Biopharmaceuticals, Inc. 18Sirnaomics, Inc. 19Keratitis – Therapeutics Assessment 20Assessment by Monotherapy Products 20Assessment by Combination Products 21Assessment by Route of Administration 22Assessment by Molecule Type 24Drug Profiles 26Brivudin - Drug Profile 26Product Description 26Mechanism of Action 26
  3. 3. R&D Progress 26RGN-259 - Drug Profile 27Product Description 27Mechanism of Action 27List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Blepharitis – Pipeline Review, H1 2012Polypoidal Choroidal Vasculopathy – Pipeline Review, H1 2012Low Cardiac Output Syndrome – Pipeline Review, H1 2012Keratitis – Pipeline Review, H1 2012Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) – Pipeline Review, H12012Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012
  4. 4. Thyroid Gland Disorders – Pipeline Review, H1 2012Tinea Corporis – Pipeline Review, H1 2012Pulmonary Fibrosis – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: